Literature DB >> 8710060

Ten steps in characterizing and diagnosing patients with peripheral neuropathy.

P J Dyck1, P J Dyck1, I A Grant, R D Fealey.   

Abstract

Cost-effective approaches for arriving at correct diagnoses should be used. Herein, we compare three approaches for the differential diagnosis of a common neurologic syndrome, peripheral neuropathy. In the "shotgun" approach, a standard battery of hematologic, biochemical, serologic, antibody, enzyme, molecular genetic, and other tests are ordered after the presence of a neuropathy is established, without a detailed characterization of the neuropathy. In the "gestalt" approach, the specific variety of neuropathy is identified by recognition of a clinical pattern of symptoms, course, or disease associations. The "10-step" approach, encompassing components of the two other methods and adding others, evolved from our assessment of many patients with peripheral neuropathy. In the 10-step approach, the history and neurologic examination place the patient's disorder into one of perhaps 21 anatomic-pathologic patterns. Next, electrophysiologic and other tests confirm the correctness of this anatomic-pathologic patterns. Finally, a series of evaluations exclude or include an increasingly shorter list of diagnoses until only one likely one remains or the disorder remains undiagnosed. We advocate the 10-step over the shotgun or gestalt approach, because it emphasizes careful initial characterization of neuropathy and emphasizes use of a logical step-by-step inclusion or exclusion to arrive at a short list of diagnostic possibilities. The approach depends ultimately on the judgement of adequately trained and experienced physicians, not on the results of single tests. The 10-step approach is not a mindless algorithm, leading inevitably to the correct diagnosis, but depends on judgment based on extensive background and neurobiologic and clinical knowledge and training.

Entities:  

Mesh:

Year:  1996        PMID: 8710060     DOI: 10.1212/wnl.47.1.10

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  9 in total

1.  Effects of light fingertip touch on postural responses in subjects with diabetic neuropathy.

Authors:  R Dickstein; R J Peterka; F B Horak
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-05       Impact factor: 10.154

Review 2.  Clinical utility of autoantibodies in Guillain-Barre syndrome and its variants.

Authors:  J W Terryberry; Y Shoenfeld; J B Peter
Journal:  Clin Rev Allergy Immunol       Date:  1998       Impact factor: 8.667

Review 3.  [Immune-mediated neuropathies].

Authors:  G Stoll; K Reiners
Journal:  Nervenarzt       Date:  2016-08       Impact factor: 1.214

4.  Diagnostic investigation of patients with chronic polyneuropathy: evaluation of a clinical guideline.

Authors:  N R Rosenberg; P Portegies; M de Visser; M Vermeulen
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-08       Impact factor: 10.154

Review 5.  [Polyneuropathy in the elderly].

Authors:  Wolfgang Löscher; Bernhard Iglseder
Journal:  Z Gerontol Geriatr       Date:  2017-04-28       Impact factor: 1.281

Review 6.  Peripheral neuropathies in rheumatic disease--a guide to diagnosis.

Authors:  Jean-Michel Vallat; Magalie Rabin; Laurent Magy
Journal:  Nat Rev Rheumatol       Date:  2012-08-21       Impact factor: 20.543

7.  Additional causes for distal sensory polyneuropathy in diabetic patients.

Authors:  K C Gorson; A H Ropper
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-03       Impact factor: 10.154

Review 8.  Drug-induced hyperhidrosis and hypohidrosis: incidence, prevention and management.

Authors:  William P Cheshire; Robert D Fealey
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

9.  Polyneuropathy with Impaired Glucose Tolerance: Implications for Diagnosis and Therapy.

Authors:  J Robinson Singleton; A Gordon Smith; James Russell; Eva L Feldman
Journal:  Curr Treat Options Neurol       Date:  2005-01       Impact factor: 3.972

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.